For each condition and drug class, the option to favour on today's market - refreshed every working day. A guide to value within clinically comparable choices, never a substitute for your clinical judgement.
This universal board sticks to generic, clinically-comparable choices. The brand-specific opportunities are reserved for the tailored deep-dive report.
Best value today: Pennecaldor leads this class on live dispensing value. Options are clinically comparable within guidance, so favour the value-leader where suitable.
| Molecule | Form | Value | In class |
|---|---|---|---|
| PennecaldorPrefer | 37mg tablets · 30 | in stock | |
| Tivmical | 26mg tablets · 28 | alternative | |
| Xaquo | 13mg tablets · 28 | alternative | |
| Ranyxip | 9mg tablets · 250 | alternative |
Colour shades each option by its live dispensing value (deeper green = higher value). Molecules are clinically interchangeable within guidance; order reflects dispensary value, not clinical priority.
Best value today: Muvdorvorcal leads this class on live dispensing value. Options are clinically comparable within guidance, so favour the value-leader where suitable.
| Molecule | Form | Value | In class |
|---|---|---|---|
| MuvdorvorcalPrefer | 11mg tablets · 28 | in stock | |
| Lyxlosil | 33mg tablets · 28 | alternative | |
| Bexsil | 2.4mg tablets · 28 | alternative | |
| Fynnyxgar | 7mg tablets · 28 | alternative |
Colour shades each option by its live dispensing value (deeper green = higher value). Molecules are clinically interchangeable within guidance; order reflects dispensary value, not clinical priority.
Best value today: Vaquovaip leads this class on live dispensing value. Options are clinically comparable within guidance, so favour the value-leader where suitable.
| Molecule | Form | Value | In class |
|---|---|---|---|
| VaquovaipPrefer | 6mg Pennerin · 28 | in stock | |
| Somipnedor | 4mg tablets · 28 | alternative | |
| Tusil | 8mg tablets · 28 | alternative |
Colour shades each option by its live dispensing value (deeper green = higher value). Molecules are clinically interchangeable within guidance; order reflects dispensary value, not clinical priority.
Best value today: Valo leads this class on live dispensing value. Options are clinically comparable within guidance, so favour the value-leader where suitable.
| Molecule | Form | Value | In class |
|---|---|---|---|
| ValoPrefer | 490mg tablets · 500 | in stock | |
| Valo | 490mg Pennerin · 56 | alternative |
Colour shades each option by its live dispensing value (deeper green = higher value). Molecules are clinically interchangeable within guidance; order reflects dispensary value, not clinical priority.
Best value today: Muvpen leads this class on live dispensing value. Options are clinically comparable within guidance, so favour the value-leader where suitable.
| Molecule | Form | Value | In class |
|---|---|---|---|
| MuvpenPrefer | 102mg tablets · 30 | in stock | |
| Muvfyn | 7mg tablets · 28 | alternative | |
| Bexhodquo | 13mg tablets · 28 | alternative |
Colour shades each option by its live dispensing value (deeper green = higher value). Molecules are clinically interchangeable within guidance; order reflects dispensary value, not clinical priority.
Best value today: Tivcalsom leads this class on live dispensing value. Options are clinically comparable within guidance, so favour the value-leader where suitable.
| Molecule | Form | Value | In class |
|---|---|---|---|
| TivcalsomPrefer | 4mg tablets · 28 | in stock | |
| Zensomnyxbex | 123mg tablets · 28 | alternative | |
| Rinjunne | 23mg tablets · 28 | alternative |
Colour shades each option by its live dispensing value (deeper green = higher value). Molecules are clinically interchangeable within guidance; order reflects dispensary value, not clinical priority.
Best value today: Junolt leads this class on live dispensing value. Options are clinically comparable within guidance, so favour the value-leader where suitable.
| Molecule | Form | Value | In class |
|---|---|---|---|
| JunoltPrefer | 89mg tablets · 60 | in stock | |
| Junolt | 44mg tablets · 28 | alternative |
Colour shades each option by its live dispensing value (deeper green = higher value). Molecules are clinically interchangeable within guidance; order reflects dispensary value, not clinical priority.
Best value today: Xafynzen leads this class on live dispensing value. Options are clinically comparable within guidance, so favour the value-leader where suitable.
| Molecule | Form | Value | In class |
|---|---|---|---|
| XafynzenPrefer | 24mg capsules · 250 | in stock | |
| Zenxa | 31mg capsules · 100 | alternative | |
| Pramigar | 22mg capsules · 28 | alternative |
Colour shades each option by its live dispensing value (deeper green = higher value). Molecules are clinically interchangeable within guidance; order reflects dispensary value, not clinical priority.
Best value today: Nyxvor Ulmmi leads this class on live dispensing value. Options are clinically comparable within guidance, so favour the value-leader where suitable.
| Molecule | Form | Value | In class |
|---|---|---|---|
| Nyxvor UlmmiPrefer | 209ml oral solution | in stock | |
| Ulmulmtivtiv Ulmmi | 526ml oral solution | alternative | |
| Penmipra | 397ml oral solution | alternative | |
| Nyxvor Ulmmi | 418mg tablets · 60 | alternative | |
| Ulmulmtivtiv | 445ml oral solution | alternative |
Colour shades each option by its live dispensing value (deeper green = higher value). Molecules are clinically interchangeable within guidance; order reflects dispensary value, not clinical priority.
Best value today: Xador leads this class on live dispensing value. Options are clinically comparable within guidance, so favour the value-leader where suitable.
| Molecule | Form | Value | In class |
|---|---|---|---|
| XadorPrefer | 627ml oral solution | in stock | |
| Trovorquowex | 6.5mg tablets · 60 | alternative | |
| Wexvavor | 15660mg sachets · 30 | alternative |
Colour shades each option by its live dispensing value (deeper green = higher value). Molecules are clinically interchangeable within guidance; order reflects dispensary value, not clinical priority.
Best value today: Junxa leads this class on live dispensing value. Options are clinically comparable within guidance, so favour the value-leader where suitable.
| Molecule | Form | Value | In class |
|---|---|---|---|
| JunxaPrefer | 16mg tablets · 28 | in stock | |
| Muvne | 22mg capsules · 30 | alternative | |
| Tivsom | 35mg tablets · 28 | alternative |
Colour shades each option by its live dispensing value (deeper green = higher value). Molecules are clinically interchangeable within guidance; order reflects dispensary value, not clinical priority.
Best value today: Calzentivsom leads this class on live dispensing value. Options are clinically comparable within guidance, so favour the value-leader where suitable.
| Molecule | Form | Value | In class |
|---|---|---|---|
| CalzentivsomPrefer | 70mg Pennerin · 28 | in stock | |
| Nyxwexpravor | 10mg tablets · 30 | alternative |
Colour shades each option by its live dispensing value (deeper green = higher value). Molecules are clinically interchangeable within guidance; order reflects dispensary value, not clinical priority.
Best value today: Muvlocalzen Vaulmdormuv leads this class on live dispensing value. Options are clinically comparable within guidance, so favour the value-leader where suitable.
| Device / molecule | Form | Value | In class |
|---|---|---|---|
| Muvlocalzen VaulmdormuvPrefer | 100 inhaler | in stock | |
| Muvlocalzen | 100 inhaler | alternative | |
| Zenwexpratu | 108mcg inhaler | alternative | |
| Muvgargar | 100 inhaler · 100 | alternative | |
| Garpragar | 100 inhaler · 200 | alternative |
Colour shades each option by its live dispensing value (deeper green = higher value). Molecules are clinically interchangeable within guidance; order reflects dispensary value, not clinical priority.
Best value today: Korfyntro leads this class on live dispensing value. Options are clinically comparable within guidance, so favour the value-leader where suitable.
| Device / molecule | Form | Value | In class |
|---|---|---|---|
| KorfyntroPrefer | 100 inhaler · 200 | in stock | |
| Garlovorpra | 100 inhaler | alternative |
Colour shades each option by its live dispensing value (deeper green = higher value). Molecules are clinically interchangeable within guidance; order reflects dispensary value, not clinical priority.
Best value today: Dorhodjunva leads this class on live dispensing value. Options are clinically comparable within guidance, so favour the value-leader where suitable.
| Device / molecule | Form | Value | In class |
|---|---|---|---|
| DorhodjunvaPrefer | 100/6 inhaler | in stock |
Colour shades each option by its live dispensing value (deeper green = higher value). Molecules are clinically interchangeable within guidance; order reflects dispensary value, not clinical priority.
Best value today: Trovortrosil leads this class on live dispensing value. Options are clinically comparable within guidance, so favour the value-leader where suitable.
| Molecule | Form | Value | In class |
|---|---|---|---|
| TrovortrosilPrefer | 440mg tablets · 1000 | in stock |
Colour shades each option by its live dispensing value (deeper green = higher value). Molecules are clinically interchangeable within guidance; order reflects dispensary value, not clinical priority.
Best value today: Pralomuvolt leads this class on live dispensing value. Options are clinically comparable within guidance, so favour the value-leader where suitable.
| Molecule | Form | Value | In class |
|---|---|---|---|
| PralomuvoltPrefer | 269mg tablets · 84 | in stock | |
| Calvava | 174mg tablets · 56 | alternative | |
| Calvava | 349mg tablets · 250 | alternative |
Colour shades each option by its live dispensing value (deeper green = higher value). Molecules are clinically interchangeable within guidance; order reflects dispensary value, not clinical priority.
Best value today: Korvorhod leads this class on live dispensing value. Options are clinically comparable within guidance, so favour the value-leader where suitable.
| Molecule | Form | Value | In class |
|---|---|---|---|
| KorvorhodPrefer | 6mg tablets · 28 | in stock | |
| Rinrarin | 235mg capsules · 100 | alternative |
Colour shades each option by its live dispensing value (deeper green = higher value). Molecules are clinically interchangeable within guidance; order reflects dispensary value, not clinical priority.
Best value today: Trohodsommuv leads this class on live dispensing value. Options are clinically comparable within guidance, so favour the value-leader where suitable.
| Molecule | Form | Value | In class |
|---|---|---|---|
| TrohodsommuvPrefer | 423ml cream | in stock | |
| Fynra Lyxrin | 618g cream | alternative | |
| Bexpra | 321g gel | alternative | |
| Sombex | 557g cream | alternative | |
| Fynkorvafyn Silrinkor | 459g cream | alternative | |
| Calquorin | 345g cream | alternative | |
| Fyngar | 527g cream | alternative | |
| Lotro | 481g ointment | alternative | |
| Quotro | 394g cream | alternative | |
| Juntrohodgar | 424g cream | alternative | |
| Bexbexkor | 621g gel | alternative | |
| Tivhod | 344g cream | alternative | |
| Silulm Somquofyn | 318ml cream | alternative | |
| Somhodmi | 608ml cream | alternative |
Colour shades each option by its live dispensing value (deeper green = higher value). Molecules are clinically interchangeable within guidance; order reflects dispensary value, not clinical priority.
Best value today: Somtivpen leads this class on live dispensing value. Options are clinically comparable within guidance, so favour the value-leader where suitable.
| Molecule | Form | Value | In class |
|---|---|---|---|
| SomtivpenPrefer | 27g cream | in stock | |
| Rinpracalolt | 19g cream | alternative |
Colour shades each option by its live dispensing value (deeper green = higher value). Molecules are clinically interchangeable within guidance; order reflects dispensary value, not clinical priority.
Best value today: Dorhodipulm Lotrosilxa leads this class on live dispensing value. Options are clinically comparable within guidance, so favour the value-leader where suitable.
| Molecule | Form | Value | In class |
|---|---|---|---|
| Dorhodipulm LotrosilxaPrefer | 38g cream | in stock | |
| Zennyx | 21g ointment | alternative |
Colour shades each option by its live dispensing value (deeper green = higher value). Molecules are clinically interchangeable within guidance; order reflects dispensary value, not clinical priority.
Best value today: Vajunkor Dorturajun Vorlolyx leads this class on live dispensing value. Options are clinically comparable within guidance, so favour the value-leader where suitable.
| Molecule | Form | Value | In class |
|---|---|---|---|
| Vajunkor Dorturajun VorlolyxPrefer | 7ml drops | in stock | |
| Gardortutro Vorulmsiltu Wexvor | 7ml drops | alternative | |
| Vajunkor Dorturajun | 424mg gel · 30 | alternative | |
| Troratro Ulmpravor | 12ml drops | alternative | |
| Quoiplo | 9ml drops | alternative | |
| Iplyxmi Dorturajun | 25mg/6mg/6ml drops | alternative | |
| Varamuv | 0.3ml drops · 30 | alternative | |
| Wexmuv Nelora | 12ml | alternative | |
| Troratro | 11ml drops | alternative | |
| Tivmipra | 4ml drops | alternative | |
| Calcalmuv | 0.2%/11g gel | alternative | |
| Oltcalrin Nelora | 7ml drops | alternative | |
| Wexrabexip | 10ml | alternative | |
| Oltcalrin Ulmkormuv | 10ml drops | alternative | |
| Milorativ | 7ml drops | alternative | |
| Garjunquopra | 8ml drops | alternative | |
| Kortuippen | 9ml drops | alternative | |
| Gardortutro Minyx | 12ml drops | alternative | |
| Ipmi | 0.3mg/3ml drops | alternative | |
| Silmifyn | 6ml drops | alternative | |
| Rapravorxa | 9ml | alternative | |
| Gardortutro | 12g gel | alternative | |
| Vatrovacal | 8ml drops | alternative | |
| Garxa Minyx | 10ml drops | alternative | |
| Iplyxmi | 18mg/5ml drops | alternative | |
| Oltcalrin Lyxrin Nelora | 8ml drops | alternative | |
| Garxa Calcalmuv | 12g gel | alternative |
Colour shades each option by its live dispensing value (deeper green = higher value). Molecules are clinically interchangeable within guidance; order reflects dispensary value, not clinical priority.
Best value today: Tivolt leads this class on live dispensing value. Options are clinically comparable within guidance, so favour the value-leader where suitable.
| Molecule | Form | Value | In class |
|---|---|---|---|
| TivoltPrefer | 41mcg drops · 30 | in stock | |
| Vorpenvorva/Prazenvor | 1.9ml drops | alternative | |
| Ulmlyx | 0.1mg/3ml drops | alternative | |
| Hodcalpenvor | 58mcg/2.9ml drops | alternative | |
| Ulmlyx/Prazenvor | 0.2mg/3mg/2ml | alternative | |
| Vorpenvorva | 45mcg/2.3ml drops | alternative | |
| Ulmlyx | 0.3mg/0.4ml · 30 | alternative | |
| Ulmvahod | 18mcg drops · 30 | alternative | |
| Dorolt | 33mcg/2.1ml drops | alternative | |
| Ulmlyx | 0.3mg/3ml drops | alternative |
Colour shades each option by its live dispensing value (deeper green = higher value). Molecules are clinically interchangeable within guidance; order reflects dispensary value, not clinical priority.
Best value today: Koripralyx leads this class on live dispensing value. Options are clinically comparable within guidance, so favour the value-leader where suitable.
| Molecule | Form | Value | In class |
|---|---|---|---|
| KoripralyxPrefer | 1mg/0.5ml gel · 30 | in stock | |
| Prazenvor | 4ml drops | alternative |
Colour shades each option by its live dispensing value (deeper green = higher value). Molecules are clinically interchangeable within guidance; order reflects dispensary value, not clinical priority.
Best value today: Somtiv/Prazenvor leads this class on live dispensing value. Options are clinically comparable within guidance, so favour the value-leader where suitable.
| Molecule | Form | Value | In class |
|---|---|---|---|
| Somtiv/PrazenvorPrefer | 10ml drops · 10ml | in stock | |
| Fynoltzen/Prazenvor | 9mg/4mg/4ml | alternative | |
| Fynoltzen | 9mg/4ml drops | alternative | |
| Dorbex | 4ml drops | alternative | |
| Somtiv | 17mg drops | alternative |
Colour shades each option by its live dispensing value (deeper green = higher value). Molecules are clinically interchangeable within guidance; order reflects dispensary value, not clinical priority.